Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.56 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | APEX1 | P27695 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 6/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11127572 | 1.00 | TSHR (0.56) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL2740452 | 1.00 | TSHR (0.56) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL13105980 | 1.00 | TSHR (0.56) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL29944765 | 1.00 | TSHR (0.56) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL13555731 | 0.94 | THRB (0.61) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL31250026 | 0.94 | THRB (0.61) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL27688824 | 0.93 | TSHR (0.62) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL5909577 | 0.92 | TSHR (0.61) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL6115523 | 0.92 | TSHR (0.61) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL4933888 | 0.92 | TSHR (0.61) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220018042-A1 | METHOD FOR PRODUCING POLYURETHANE ELASTIC FIBER | SANKO CO LTD (JP) | 2022-01-20 | — | — | US | disclosed |
| US-9500777-B2 | Antireflection film, polarizing plate, image display device and a manufacturing method for antireflection film | FUJIFILM CORPORATION (JP) | 2016-11-22 | — | — | US | disclosed |
| US-9389339-B2 | Method for producing antireflection film, antireflection film, and coating composition | FUJIFILM CORPORATION (JP) | 2016-07-12 | — | — | US | disclosed |
| US-20160187540-A2 | METHOD FOR PRODUCING ANTIREFLECTION FILM, ANTIREFLECTION FILM, AND COATING COMPOSITION | FUJIFILM CORPORATION (JP) | 2016-06-30 | — | — | US | disclosed |
| US-20150253466-A1 | ANTIREFLECTION FILM, POLARIZING PLATE, IMAGE DISPLAY DEVICE AND A MANUFACTURING METHOD FOR ANTIREFLECTION FILM | FUJIFILM CORPORATION (JP) | 2015-09-10 | — | — | US | disclosed |
| US-8679578-B2 | Method of manufacturing anti-reflection film, anti-reflection film and coating composition | FUJIFILM CORPORATION (JP) | 2014-03-25 | — | — | US | disclosed |
| US-8524116-B2 | Multilayer sheet containing optically anisotropic layer containing liquid crystal compound and cellulose ester with polymer | FUJIFILM CORPORATION (JP) | 2013-09-03 | — | — | US | disclosed |
| US-20130084442-A1 | METHOD OF MANUFACTURING ANTI-REFLECTION FILM, ANTI-REFLECTION FILM AND COATING COMPOSITION | FUJIFILM CORPORATION (JP) | 2013-04-04 | — | — | US | disclosed |
| US-20120270021-A1 | METHOD FOR PRODUCING ANTIREFLECTION FILM, ANTIREFLECTION FILM, AND COATING COMPOSITION | FUJIFILM CORPORATION (JP) | 2012-10-25 | — | — | US | disclosed |
| US-20110242654-A1 | Hardcoat layer-forming composition, optical film, production method of optical film, polarizing plate and image display device | FUJIFILM CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-7872716-B2 | Optical compensation film, polarizing plate and liquid crystal display | FUJIFILM CORPORATION (JP) | 2011-01-18 | — | — | US | disclosed |
| US-20100075070-A1 | OPTICAL FILM, POLARIZING PLATE, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20090066898-A1 | OPTICALLY-COMPENSATORY SHEET, ELLIPSOIDAL POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20080199637-A1 | Optical Compensatory Film, Process for Producing the Same, and Polarizing Plate and Liquid Crystal Display Employing the Same | FUJIFILM CORPORATION (JP) | 2008-08-21 | — | — | US | disclosed |
| US-20080192191-A1 | Optical Compensation Film, Polarizing Plate and Liquid Crystal Display | FUJIFILM CORPORATION (JP) | 2008-08-14 | — | — | US | disclosed |
| US-7315341-B2 | Liquid crystal display device with retardation layer with different relative humidity | FUJIFILM CORPORATION (JP) | 2008-01-01 | — | — | US | disclosed |
| US-7311949-B2 | Composition, optical film, polarizing plate and liquid crystal display | FUJIFILM CORPORATION (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070002232-A1 | Optical compensation film, polarizing plate and liquid crystal display device | FUJI PHOTO FILM CO., LTD. (JP) | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090066898-A1 | OPTICALLY-COMPENSATORY SHEET, ELLIPSOIDAL POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY DEVICE | SMN1; SMN2, SPOP, RHOXF2 | TSHR 4242/4885THRB 4467/4885POLB 1619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.